Search Results for: viacyte

Great News: FDA Nod For ViaCyte IND of Diabetes Stem Cell-Based Product

ViaCyte-logo-3x2

Type 1 Diabetes is a huge global problem. Where are the solutions that would compliment or replace insulin therapy for diabetics? There haven’t been too many that have gotten very far, which makes the news of a potential stem cell-based therapy moving along in the pipeline all the more exciting. ViaCyte (see more posts here, …

Great News: FDA Nod For ViaCyte IND of Diabetes Stem Cell-Based Product Read More »

Viacyte & Mesoblast present at CIRM Meeting

Allan Robins of Viacyte (pictured at left–sorry for the fuzzy image) and Paul Simmons of Mesoblast presented this morning at the CIRM Grantee Meeting. Both talks were outstanding. Robins went first. He started by saying how Viacyte had a productive pre-IND meeting with the FDA last year. I believe a target for them is to …

Viacyte & Mesoblast present at CIRM Meeting Read More »

The recipe for success for stem cell biotechs such as Geron, ACT, and ViaCyte: 3 key ingredients

What will we define as a success for any given stem cell biotech? In academia, even if we do pre-clinical, translational kind of biomedical sciences, we still do not often think about what it takes to succeed in industry. Even if we very much want our research to make a difference for patients, do we …

The recipe for success for stem cell biotechs such as Geron, ACT, and ViaCyte: 3 key ingredients Read More »

Clinical Trials Part II: Viacyte Director of Stem Cell Research Dr. D’Amour speaking today in Seattle

Dr. Kevin D’Amour, Director of Stem Cell Research at Viacyte, gave an excellent, extremely interesting talk Friday morning: Developing an Encapsulated Stem Cell Therapy for Diabetes. In the talk, Dr. D’Amour gave a very detailed description of their products Pro-Islet and Encaptra. Together these products form an encapsulated beta-cell product that is in pre-clinical development …

Clinical Trials Part II: Viacyte Director of Stem Cell Research Dr. D’Amour speaking today in Seattle Read More »

16 predictions for stem cells & regenerative medicine in 2022

regenerative medicine, stem cells 2021

The last few years in the stem cell and regenerative medicine arena have been complicated in many ways. Variables like surging stem cell clinics and COVID have made predictions harder. ¬†Even so, trying to make predictions is useful and it’s fun to go over past year’s predictions. You can see my scorecard on my 2021 …

16 predictions for stem cells & regenerative medicine in 2022 Read More »

Top stem cell stories of 2021: COVID, diabetes, human embryos, clinics in court

regenerative medicine, stem cells 2021

The past year was all over the place for the stem cell and regenerative medicine field. As you can see in my scoring of my 21 predictions for 2021, quite a few things were surprises in terms of what did and didn’t happen. Here’s an overview of the top stories of the year in our …

Top stem cell stories of 2021: COVID, diabetes, human embryos, clinics in court Read More »

Grading my 21 stem cell & regenerative medicine predictions for 2021

stem-cell-crystal-ball-300x3001

The world of stem cell research and regenerative medicine is unpredictable but it’s fun to be a part of it and try to do predictions. Each year in late December or early January I make prognostications for the coming year for stem cell research and regenerative medicine. I made 21 such predictions for the current …

Grading my 21 stem cell & regenerative medicine predictions for 2021 Read More »

Weekly reads: grad student life, cell barcoding, diabetes trial, more

ViaCyte capsule stem cells diabetes

Part of being a grad student is dealing with technologies related to your projects and their limitations. Sometimes I feel old when I remember the way we used to have to do things in the lab. As a grad student, I manually poured, ran, and read giant sequencing gels. Back then, gene synthesis of a …

Weekly reads: grad student life, cell barcoding, diabetes trial, more Read More »

Regenerative reads: 3 CRISPR babies, FDA warning, diabetes, pubs

CRISPR-baby

If you celebrate the Thanksgiving holiday I hope you had a nice one and, right before it started a new article popped on the scene about the CRISPR babies. Before we discuss those three gene-edited people, who are now growing up into little kids, we hit a milestone on our YouTube Stem Cell Channel with …

Regenerative reads: 3 CRISPR babies, FDA warning, diabetes, pubs Read More »

Startup Clade from CRISPR Therapeutics founder pursues cloaked stem cells for cancer therapy

Chad-Cowan CRISPR Therapeutics

CRISPR Therapeutics has been pursuing the idea of using gene-editing to make universally compatible stem cells for some time, but there’s an new development in this space. The potential here is big. What if you could make cloaked stem cells that could be used to produce cellular therapies that could be given to most patients …

Startup Clade from CRISPR Therapeutics founder pursues cloaked stem cells for cancer therapy Read More »